Is Administration of Preoperative Angiotensin-Converting Enzyme Inhibitors Important for Renal Protection after Cardiac Surgery?

REFERENCES

• Rady MY, Ryan T. The effects of preoperative therapy with angiotensin-converting enzyme inhibitors on clinical outcome after cardiovascular surgery. Chest. 1998;114:487–494.
   PubMed Web of Science ®Google Scholar
• Baue AE. Multiple organ failure, multiple organ dysfunction syndrome and systemic inflammatory response syndrome: why no magic bullets? Arch Surg. 1997;132:703–707.
   PubMedGoogle Scholar
• Ryckwaert F, Colson P, Ribstein J, Boccara G, Guillon G. Hemodynamic and renal effects of intravenous enalaprilat during coronary artery bypass graft surgery in patients with ischemic heart dysfunction. Br J Anaesth. 2001;86:169–175.
   PubMed Web of Science ®Google Scholar
• American Heart Association. Heart Disease and Stroke Statistics: 2005 Uptake. Dallas, TX: American Heart Association; 2005.
   Google Scholar
• Benedetto U, Sciarretta S, Roscitano A, . Preoperative angiotensin-converting enzyme inhibitors and acute kidney injury after coronary artery bypass grafting. Ann Thorac Surg. 2008;86:1160–1166.
   PubMed Web of Science ®Google Scholar
• Boldt J, Schindler E, Wollbruck M, . Cardiorespiratory response of intravenous Enalaprilat in hypertensive cardiac surgeiy patients. J Cardiothorac Vase Anesth. 1995;9:44–49.
   PubMed Web of Science ®Google Scholar
• Mann JF, Gerstein HC, Yi QL, . Development of renal disease in people at high cardiovascular risk: results of the HOPE randomized study. J Am Soc Nephrol. 2003;14:641–647.
   PubMed Web of Science ®Google Scholar
• Marre M, Lievre M, Chatellier G, Mann JF, Passa P, Ménard J. DIABHYCAR Study Investigators. Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study). BMJ. 2004;328:495–498.
   PubMed Web of Science ®Google Scholar
• Bakris GL, Weir MR. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med. 2000;160:685–693.
   PubMed Web of Science ®Google Scholar
• Böttiger BW, Rauch H, Böhrer H, . Continuous versus intermittent cardiac output measurement in cardiac surgical patients undergoing hypothermic cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 1995;9:405–411.
   PubMed Web of Science ®Google Scholar
• Colson P, Ribstein J, Mimran A, Grolleau D, Chaptal PA, Roquefeuil B. Effect of angiotensin converting enzyme inhibition on blood pressure and renal function during open heart surgery. Anesthesiology. 1990;72:23–27.
   PubMed Web of Science ®Google Scholar
• Gottlieb SS, Weir MR. Renal effects of angiotensin converting enzyme inhibition in congestive heart failure. Am J Cardiol. 1990;66:14–21.
   Web of Science ®Google Scholar
• Lonn EM, Yusuf S, Jha P, . Emerging role of angiotensin converting enzyme inhibitors in cardiac and vascular protection. Circulation. 1994;90:2056–2069.
   PubMed Web of Science ®Google Scholar
• Lyons D, Webster J, Benjamin N. Adrenergic sympathetic constrictor action in humans. Circulation. 1995;91: 1457–1459.
   PubMed Web of Science ®Google Scholar
• Gamoso MG, Phillips-Bute B, Landolfo KP, Newman MF, Stafford-Smith M. Off-pump versus on-pump coronary artery bypass surgery and postoperative renal dysfunction. Anesth Analg. 2000;91:1080–1084.
   PubMed Web of Science ®Google Scholar
• Wagner F, Yeter R, Bisson S, Siniawski H, Hetzer R. Beneficial hemodynamic and renal effects of intravenous enalaprilat following coronary artery bypass surgery complicated by left ventricular dysfunction. Crit Care Med. 2003;31:1421–1428.
   PubMed Web of Science ®Google Scholar
• Argenziano M, Chen JM, Choudhri AF, . Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg. 1998;116:973–980.
   PubMed Web of Science ®Google Scholar
• Mehta RH, Grab JD, O’Brien SM, . Society of Thoracic Surgeons National Cardiac Surgery Database Investigators. Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery. Circulation. 2006;114:2208–2216.
   PubMed Web of Science ®Google Scholar
• Brown JR, Cochran RP, Leavitt BJ, . Northern New England Cardiovascular Disease Study Group. Multivariable prediction of renal insufficiency developing after cardiac surgery. Circulation. 2007;116:I139–I143.
   Web of Science ®Google Scholar
• Thakar CV, Worley S, Arrigain S, Yared JP, Paganini EP. Influence of renal dysfunction on mortality after cardiac surgery: modifying effect of preoperative renal function. Kidney Int. 2005;67:1112–1119.
   PubMed Web of Science ®Google Scholar
• Thakar CV, Worley S, Arrigain S, Yared JP, Paganini EP. Improved survival in acute kidney injury after cardiac surgery. Am J Kidney Dis. 2007;50:703–711.
   PubMed Web of Science ®Google Scholar
• Wijeysundera DN, Karkouti K, Dupuis JY, . Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery. J Am Med Assoc. 2007;297:1801–1809.
   PubMed Web of Science ®Google Scholar
• Topkara VK, Cheema FH, Kesavaramanujam S, . Coronary artery bypass grafting in patients with low ejection fraction. Circulation. 2005;112:I344–I350.
   PubMed Web of Science ®Google Scholar
• Andersen S, Tarnow L, Cambien F, . Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype? Diabetes Care. 2003;26(5):1501–1506.
   PubMed Web of Science ®Google Scholar
• Ljutić D, Kes P. The role of arterial hypertension in the progression of non-diabetic glomerular diseases. Nephrol Dial Transplant. 2003;18(Suppl. 5):28–30.
   Google Scholar
• Kes P, Basić-Jukić N, Ljutić D, Brunetta-Gavranić B. The role of arterial hypertension in developement of chronic renal failure. Acta Med Croatica. 2011;65(Suppl. 3):78–84.
   PubMedGoogle Scholar
• Mansoor AM, Honda M, Kuramochi T, . Effects of ACE inhibition and beta-blockade on collagen remodeling in the heart of Bio 14.6 hamsters. Clin Exp Pharamacol Physiol. 1996;23: 43–49.
   PubMed Web of Science ®Google Scholar
• Patten RD, Kronenberg MW, Benedict CR, . Acute and long-term effects of the angiotensin converting enzyme inhibitor, enalapril, on adrenergic activity and sensitivity during exercise in patients with left ventricular systolic dysfunction. Am Heart J. 1997;134:37–43.
   PubMed Web of Science ®Google Scholar